Literature DB >> 14996497

The interplay between the Bcl-2 family and death receptor-mediated apoptosis.

Martin R Sprick1, Henning Walczak.   

Abstract

Two principal pathways for apoptosis initiation exist. One pathway, which is also termed the 'extrinsic' pathway, is mediated by death receptors, a subgroup of the TNF receptor superfamily. The second pathway, which is also referred to as the 'intrinsic' pathway is controlled by members of the Bcl-2 family. A long standing discussion revolves around the question of how these two pathways influence each other in regulating the decision about life or death of a cell. Here, we review our current knowledge about the interactions between these two pathways and discuss current models which could help to resolve previous apparently contradictory results.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996497     DOI: 10.1016/j.bbamcr.2003.11.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  42 in total

Review 1.  Role of Bcl-2 family proteins and caspases in the regulation of apoptosis.

Authors:  Mohammad Shamsul Ola; Mohd Nawaz; Haseeb Ahsan
Journal:  Mol Cell Biochem       Date:  2011-01-06       Impact factor: 3.396

2.  Nuclear factor-kappaB activation in neonatal mouse lung protects against lipopolysaccharide-induced inflammation.

Authors:  Cristina M Alvira; Aida Abate; Guang Yang; Phyllis A Dennery; Marlene Rabinovitch
Journal:  Am J Respir Crit Care Med       Date:  2007-01-25       Impact factor: 21.405

3.  Role of cytochrome C in apoptosis: increased sensitivity to tumor necrosis factor alpha is associated with respiratory defects but not with lack of cytochrome C release.

Authors:  Uma D Vempati; Francisca Diaz; Antoni Barrientos; Sonoko Narisawa; Abdul M Mian; José Luis Millán; Lawrence H Boise; Carlos T Moraes
Journal:  Mol Cell Biol       Date:  2007-01-08       Impact factor: 4.272

4.  Comparison of cell cycle components, apoptosis and cytoskeleton-related molecules and therapeutic effects of flavopiridol and geldanamycin on the mouse fibroblast, lung cancer and embryonic stem cells.

Authors:  Huseyin Aktug; Eda Acikgoz; Aysegul Uysal; Fatih Oltulu; Gulperi Oktem; Gurkan Yigitturk; Kenan Demir; Altug Yavasoglu; Vildan Bozok Cetintas
Journal:  Tumour Biol       Date:  2016-06-21

5.  Manipulation of cardiac phosphatidylinositol 3-kinase (PI3K)/Akt signaling by apoptosis regulator through modulating IAP expression (ARIA) regulates cardiomyocyte death during doxorubicin-induced cardiomyopathy.

Authors:  Youhei Kitamura; Masahiro Koide; Yoshiki Akakabe; Kiyonari Matsuo; Yoshiaki Shimoda; Yuka Soma; Takehiro Ogata; Tomomi Ueyama; Satoaki Matoba; Hiroyuki Yamada; Koji Ikeda
Journal:  J Biol Chem       Date:  2013-12-13       Impact factor: 5.157

6.  Enriching the human apoptosis pathway by predicting the structures of protein-protein complexes.

Authors:  Saliha Ece Acuner Ozbabacan; Ozlem Keskin; Ruth Nussinov; Attila Gursoy
Journal:  J Struct Biol       Date:  2012-02-14       Impact factor: 2.867

7.  Death receptor-associated pro-apoptotic signaling in aged skeletal muscle.

Authors:  Emidio E Pistilli; Janna R Jackson; Stephen E Alway
Journal:  Apoptosis       Date:  2006-12       Impact factor: 4.677

8.  Identification and functional analysis of the novel ORF4 protein encoded by porcine circovirus type 2.

Authors:  Jialing He; Jingjing Cao; Niu Zhou; Yulan Jin; Jiusheng Wu; Jiyong Zhou
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

Review 9.  Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression.

Authors:  Jong Hun Lee; Tin Oo Khor; Limin Shu; Zheng-Yuan Su; Francisco Fuentes; Ah-Ng Tony Kong
Journal:  Pharmacol Ther       Date:  2012-10-03       Impact factor: 12.310

10.  Cilostazol protects endothelial cells against lipopolysaccharide-induced apoptosis through ERK1/2- and P38 MAPK-dependent pathways.

Authors:  Jong-Hoon Lim; Jae-Suk Woo; Yung-Woo Shin
Journal:  Korean J Intern Med       Date:  2009-06-08       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.